Densitas announces the signing of a new Alliance Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute, and license densitasdensity™ directly via integration with the Blackford PlatformTM. Work will now commence to integrate densitasdensity™ with the Blackford Platform.
HALIFAX, Nova Scotia, July 24, 2018 /PRNewswire/ -- Densitas, Inc., a breast imaging analytics innovator based in Halifax, Nova Scotia, announces a recently formalized partnership with the Leeds Teaching Hospitals NHS Trust in the UK.
Breast imaging analytics innovator Densitas Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its machine learning breast density assessment software.
The software empowers radiologists with standardized, personalized and automated density reports to optimize women’s breast health and follow-up care decisions.